参考文献
[1] Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, Munday JD, Kucharski AJ, Edmunds WJ, Funk S et al: Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global health 2020.
[2] Jernigan DB: Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020. MMWR Morbidity and mortality weekly report 2020, 69(8):216-219.
[3] Johnson HC, Gossner CM, Colzani E, Kinsman J, Alexakis L, Beaute J, Wurz A, Tsolova S, Bundle N, Ekdahl K: Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2020, 25(9).
[4] Khot WY, Nadkar MY: The 2019 Novel Coronavirus Outbreak - A Global Threat. The Journal of the Association of Physicians of India 2020, 68(3):67-71.
[5] Lake MA: What we know so far: COVID-19 current clinical knowledge and research. Clinical medicine (London, England) 2020.
[6] Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun WM, Wang YP: 2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis. Journal of medical virology 2020.
[7] Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo IM, Halepoto DM, Iqbal M, Usmani AM, Hajjar W, Ahmed N: Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. European review for medical and pharmacological sciences 2020, 24(4):2012-2019.
[8] Sun P, Qie S, Liu Z, Ren J, Li K, Xi J: Clinical characteristics of 50 466 hospitalized patients with 2019-nCoV infection. Journal of medical virology 2020.
[9] Li Y, Zhao R, Zheng S, Chen X, Wang J, Sheng X, Zhou J, Cai H, Fang Q, Yu F et al: Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerging infectious diseases 2020, 26(6).
[10] Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, Zhu W: Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Investigative radiology 2020.
[11] Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, Xia S, Zhou W: Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational pediatrics 2020, 9(1):51-60.
[12] Wassenaar TM, Zou Y: 2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses. Letters in applied microbiology 2020.
[13] Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J et al: Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell host & microbe 2020, 27(3):325-328.
[14] Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C: The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of autoimmunity 2020:102434.
[15] Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W: Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell discovery 2020, 6:11.
[16] Lee PI, Hsueh PR: Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2020.
[17] Li YY, Wang WN, Lei Y, Zhang B, Yang J, Hu JW, Ren YL, Lu QF: [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2020, 43(0):E023.
[18] Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents 2020:105924.
[19] Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI, Gutierrez RA, Gwee SXW, Chua PEY, Yang Q et al: Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review. Journal of clinical medicine 2020, 9(3).
[20] Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y et al: Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging microbes & infections 2020, 9(1):382-385.
|